{"SPADE_UN_22309": {"Sequence Information": {"Peptide Name": "C34-Chol", "Sequence": "WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLGSGC", "Sequence Length": 38, "Biological Activity": ["Antiviral"], "Binding Target": "1. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P03377", "uniprotUrl": "http://www.uniprot.org/uniprot/P03377", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors With Extremely Potent and Long-Lasting Antiviral Activity.", "Pubmed ID": "30867304", "Reference": "J Virol. 2019;93:e02312-18", "Author": "Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30867304"}], "Mass": 4552.88, "PI": 4.21, "Net Charge": -5, "Hydrophobicity": -1.11, "Frequent Amino Acids": "ELN", "Absent Amino Acids": "AFOPUV", "Basic Residues": 3, "Acidic Residues": 8, "Hydrophobic Residues": 9, "Polar Residues": 29, "Positive Residues": 3, "Negative Residues": 8, "SPADE ID": "SPADE_UN_22309", "Similar Sequences": [{"SPADE_ID": "SPADE_N_10037", "Similarity": 1.0, "Sequence": "WMEWDREINNYTSLIHSLIEESQNQQEKN"}, {"SPADE_ID": "SPADE_UN_09769", "Similarity": 1.0, "Sequence": "MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL"}, {"SPADE_ID": "SPADE_UN_10181", "Similarity": 1.0, "Sequence": "NASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLI"}], "Hemolytic Activity": "", "Target Organism": "HIV-1 NL4-3(IC50 I=0.00000764µM),HIV-1 JRCSF(IC50 I=0.00005086µM),HIV-1 PsV(IC50 I=0.0000653µM),HIV-1 NL4-3 D36G(IC50 I=0.000012µM),HIV-1 NL4-3(IC50 I=0.000029-0.00006µM),HIV-2 ROD(IC50 I=0.000929µM),HIV-2(IC50 I=0.00053µM),HIV-1(IC50 F=0.00014361µM),Simian immunodeficiency virus (SIV)(IC50 I=0.000078-0.001605µM)"}}}